Company research / BMRN
BIOMARIN PHARMACEUTICAL INC (BMRN)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, BIOMARIN PHARMACEUTICAL INC reported revenue of $3.22B. Revenue grew 12.9% from the prior annual period.
Key ratios (year ended 2025-12-31)
12.7%
Operating margin
10.8%
Net margin
5.7%
Return on year-end equity
12.9%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.